We'll need to take up references <a href=" http://jts.co.uk/cheapest-nexium.pdf ">prevacid prilosec nexium lawsuit</a> MLM has been operating above its normalized target leverage of 2x-2.5x debt-to-EBITDA since 2008 and ended the 2013 second quarter with Fitch-calculated debt-to-LTM EBITDA of 3.1x. This compares to 2.8x during 2012 and 3.0x during 2011. Fitch expects this leverage ratio will remain above 2.5x through 2013 and will be within MLM's target range during 2014. Funds from operations (FFO)-adjusted leverage also remains elevated at 3.8x for the LTM period ending June 30, 2013. Fitch expects this leverage ratio will improve slightly to 3.7x by year-end 2013.